<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04200482</url>
  </required_header>
  <id_info>
    <org_study_id>RG1006427</org_study_id>
    <secondary_id>NCI-2019-07643</secondary_id>
    <secondary_id>10335</secondary_id>
    <nct_id>NCT04200482</nct_id>
  </id_info>
  <brief_title>Lifestyle Program (Scalable Nutrition and Physical Activity) for the Improvement of Nutrition and Physical Activity in Stage 0-III Breast Cancer Survivors</brief_title>
  <official_title>Testing a Scalable Nutrition and Physical Activity Program for Breast Cancer Survivors: A Dose-Finding Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fred Hutchinson Cancer Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Breast Cancer Research Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fred Hutchinson Cancer Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this phase II trial is to identify the most effective dose level (number of&#xD;
      classes) of a diet and physical activity lifestyle program based on how well it improves diet&#xD;
      and physical activity in stage 0-III breast cancer survivors. Study results may provide&#xD;
      researchers with information on how to best implement diet and physical activity&#xD;
      recommendations among breast cancer survivors.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OUTLINE: Participants are randomized to 1 of 2 arms.&#xD;
&#xD;
      ARM A (LOW DOSE): Participants attend one diet and physical activity class delivered remotely&#xD;
      via Zoom and receive an eHealth communication intervention for 6 months.&#xD;
&#xD;
      ARM B (HIGH DOSE): Participants attend 12 twice monthly diet and physical activity online&#xD;
      sessions delivered remotely via Zoom and receive an eHealth communication intervention for 6&#xD;
      months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 21, 2020</start_date>
  <completion_date type="Actual">October 28, 2021</completion_date>
  <primary_completion_date type="Actual">August 24, 2021</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accrual rate</measure>
    <time_frame>At 6 months</time_frame>
    <description>Accrual rate will be measured by number of participants randomized during each month of study accrual.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence: Session(s) Attendance</measure>
    <time_frame>At 6 months</time_frame>
    <description>Adherence will be measured by number of online session(s) attended per participant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Adherence: Responsiveness to eHealth communication</measure>
    <time_frame>At 6 months</time_frame>
    <description>Adherence will be measured by the number of responses to text messages per participant.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biospecimen collection rate</measure>
    <time_frame>At 6 months</time_frame>
    <description>Biospecimen collection rate will be assessed based on number of biospecimens collected.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention</measure>
    <time_frame>At 6 months</time_frame>
    <description>Retention will be measured by the number of completed study assessments per participants.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Acceptability: Questions during exit interview</measure>
    <time_frame>At 6 months</time_frame>
    <description>Acceptability will be measured by questions asking about trial acceptability in the exit questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in daily servings of fruits and vegetables per day</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>Will be assessed by 24-hour dietary recalls.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in minutes per week of moderate-to-vigorous physical activity</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>Will be assessed by 7-day accelerometer data.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in systemic inflammation</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>Will be assessed by fasting blood concentrations of high sensitivity C-reactive protein.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in gut barrier permeability</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>Will be assessed by fasting circulating levels of gut bacterial endotoxin liposaccharide-binding protein.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Anatomic Stage 0 Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage I Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IA Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IB Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage II Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IIA Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IIB Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage III Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IIIA Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IIIB Breast Cancer AJCC v8</condition>
  <condition>Anatomic Stage IIIC Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage 0 Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage I Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IA Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IB Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage II Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IIA Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IIB Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage III Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IIIA Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IIIB Breast Cancer AJCC v8</condition>
  <condition>Prognostic Stage IIIC Breast Cancer AJCC v8</condition>
  <arm_group>
    <arm_group_label>Arm A (low dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants attend one diet and physical activity class delivered remotely via Zoom and receive an eHealth communication intervention for 6 months.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm B (high dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants attend 12 twice monthly diet and physical activity online sessions delivered remotely via Zoom and receive an eHealth communication intervention for 6 months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>One Diet and Physical Activity Session</intervention_name>
    <description>Attend 1 remote diet and physical activity session</description>
    <arm_group_label>Arm A (low dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <other_name>Behavior or Lifestyle Modifications</other_name>
    <other_name>behavior modification</other_name>
    <other_name>Behavior Conditioning Therapy</other_name>
    <other_name>Behavioral Interventions</other_name>
    <other_name>Behavioral Treatments</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Electronic (e) Health (eHealth) Communication Intervention</intervention_name>
    <description>Receive eHealth communication intervention</description>
    <arm_group_label>Arm A (low dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <arm_group_label>Arm B (high dose nutrition and PA class, eHealth intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Twelve Diet and Physical Activity Group Sessions</intervention_name>
    <description>Attend 12 remote diet and physical activity sessions in 6 months</description>
    <arm_group_label>Arm B (high dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <other_name>Behavior or Lifestyle Modifications</other_name>
    <other_name>behavior modification</other_name>
    <other_name>Behavior Conditioning Therapy</other_name>
    <other_name>Behavioral Interventions</other_name>
    <other_name>Behavioral Treatments</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm A (low dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <arm_group_label>Arm B (high dose nutrition and PA class, eHealth intervention)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Quality-of-Life Assessment</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Arm A (low dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <arm_group_label>Arm B (high dose nutrition and PA class, eHealth intervention)</arm_group_label>
    <other_name>Quality of Life Assessment</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Previous diagnosis of stage 0-III breast cancer in the past 10 years at the time of&#xD;
             enrollment&#xD;
&#xD;
          -  No evidence of recurrent or metastatic disease&#xD;
&#xD;
          -  No uncontrolled diabetes mellitus defined as glycosylated hemoglobin (Hgb A1C) &gt; 8%&#xD;
&#xD;
          -  No uncontrolled hypertension per Seattle Cancer Care Alliance (SCCA) standard of care&#xD;
&#xD;
          -  At least 60 days post final chemotherapy, biologic therapy, or radiation therapy&#xD;
             and/or surgery. Current use of endocrine therapy is permitted (e.g., tamoxifen and&#xD;
             aromatase inhibitors)&#xD;
&#xD;
          -  Access to phone for study contacts&#xD;
&#xD;
          -  Access to smartphone, tablet, or computer and internet to attend online session(s) and&#xD;
             receive study electronic eHealth communication (text messages and access to website)&#xD;
&#xD;
          -  Willing and able to attend the online session(s) on Saturdays, or via online accessed&#xD;
             videos, for up to 12 sessions in 6 months&#xD;
&#xD;
          -  Successfully complete all run-in activities, including at-home and over the phone&#xD;
             assessments, 7 days of collecting physical activity data via accelerometer, and&#xD;
             providing blood and stool sample&#xD;
&#xD;
          -  Willing and able to complete all study activities for 6 months after randomization&#xD;
&#xD;
          -  Participants must consume &lt; 5 servings of fruits and vegetables per day and/or engage&#xD;
             in &lt; 150 minutes per week of moderate to vigorous physical activity, as assessed by&#xD;
             brief questionnaires&#xD;
&#xD;
          -  Participants must have an Eastern Cooperative Oncology Group (ECOG) Scale of&#xD;
             performance status score of 0 or 1 for performance status.&#xD;
&#xD;
          -  Signed physician approval for diet change and physical activity&#xD;
&#xD;
          -  Able to understand and willing to sign written informed electronic (e) consent in&#xD;
             English&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participants must not be active smokers within the past 30 days.&#xD;
&#xD;
          -  Women must not be pregnant at time of enrollment&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy E Davidson</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fred Hutch/University of Washington Cancer Consortium</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Heather Greenlee</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fred Hutch/University of Washington Cancer Consortium</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Fred Hutch/University of Washington Cancer Consortium</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>December 10, 2019</study_first_submitted>
  <study_first_submitted_qc>December 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 16, 2019</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Breast Cancer Survivors</keyword>
  <keyword>Diet</keyword>
  <keyword>eHealth</keyword>
  <keyword>Nutrition</keyword>
  <keyword>Physical Activity</keyword>
  <keyword>Breast</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Breast Carcinoma In Situ</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>August 6, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/82/NCT04200482/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

